Morgan Stanley Knock-Out ALGN/ DE000ME40CX6 /
6/28/2024 8:44:28 AM | Chg.+0.05 | Bid11:13:14 AM | Ask11:13:14 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.15EUR | +1.61% | 3.16 Bid Size: 1,000 |
3.33 Ask Size: 1,000 |
Align Technology Inc | 212.3646 USD | 12/31/2078 | Call |
GlobeNewswire
11:00 AM
Defiance ETFs Announces Monthly Distributions on $QQQY (52.55%), $JEPY (33.76%), $IWMY (57.99%), $TR...
GlobeNewswire
10:32 AM
OKX Introduces New USDC Spot Trading Pairs to Support the Growth of the USDC Ecosystem
GlobeNewswire
3:00 AM
OWENS & MINOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Owens & Minor, Inc. on Behalf of O...
GlobeNewswire
3:00 AM
BLUE ALERT: Bragar Eagel & Squire, P.C. is Investigating Bluebird bio Inc. on Behalf of Long-Term St...
GlobeNewswire
3:00 AM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
2:48 AM
LAKESIDE HOLDING LIMITED ANNOUNCES PRICING OF $6.75 MILLION INITIAL PUBLIC OFFERING
GlobeNewswire
2:22 AM
CFIUS Approval Obtained for the Planned Merger of North American Stainless, Inc. and Haynes Internat...
GlobeNewswire
2:00 AM
ROSEN, THE FIRST FILING FIRM, Encourages FutureFuel Corp. Investors to Secure Counsel Before Importa...
GlobeNewswire
1:51 AM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
1:39 AM
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
1:38 AM
Unlocking the Future of Trading with Spotrade.net: A Leader in AI Spot Signals
GlobeNewswire
1:31 AM
PATH INVESTOR ALERT: Edelson Lechtzin LLP Urges UiPath, Inc. (NYSE: PATH) Shareholders to Consult Le...
GlobeNewswire
1:30 AM
ROSEN, A LEADING LAW FIRM, Encourages Charge Enterprises, Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
1:17 AM
TMCF President and CEO Dr. Harry L. Williams has released the following statement on the FY25 House ...
GlobeNewswire
1:15 AM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fastly, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
1:10 AM
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease